NHLBI seeks a Data Coordinating Center to manage data and provide statistical support for multi-site clinical trials, requiring collaboration with a Clinical Coordinating Center.
Funder: National Institutes of Health
Due Dates: February 1, 2027 (New) | March 1, 2027 (Resubmission/Revision) | June 2, 2027 (New) | July 2, 2027 (Resubmission/Revision) | October 1, 2027 (New) | November 1, 2027 (Resubmission/Revision) | February 1, 2028 (New) | March 1, 2028 (Resubmission/Revision) | June 1, 2028 (New) | June 30, 2028 (Resubmission/Revision) | October 2, 2028 (New) | November 2, 2028 (Resubmission/Revision)
Funding Amounts: No budget cap (actual project needs must be justified), generally 5 years (up to 7 years with strong justification)
Summary: Supports independent Data Coordinating Centers for NHLBI-relevant, investigator-initiated multi-site clinical trials.
Key Information: A collaborating Clinical Coordinating Center application under PAR-27-012 must be submitted on the same due date.
The National Heart, Lung, and Blood Institute (NHLBI) supports Data Coordinating Centers (DCCs) for investigator-initiated, Phase II or later clinical trials enrolling participants at two or more recruitment sites. Supported research includes efficacy, comparative effectiveness, pragmatic, and implementation trials testing therapeutic, behavioral, or prevention strategies. Platform, adaptive, and Bayesian designs are encouraged, as is leveraging existing clinical trial networks.
Through a milestone-driven U24 cooperative agreement, the DCC provides project coordination, administration, data management, and biostatistical support for the trial proposed by its collaborating Clinical Coordinating Center (CCC). The DCC also supports study design, safety monitoring, statistical analyses, dissemination, and implementation of the CCC’s community engagement plan. Trials must address NHLBI’s research mission in heart, lung, blood, or sleep health and meet NIH’s clinical trial definition.